Navigation Links
Life Sciences Leaders to Launch Statewide 'We Work for Health' Economic Development and Jobs Campaign
Date:4/20/2009

Group to Release Groundbreaking Study on Economic Impact of Life Sciences Sector on Washington State

SEATTLE, April 20 /PRNewswire/ -- An alliance of Washington state business, academic, government and community leaders will launch "We Work for Health," a landmark statewide effort to enhance the public's understanding of the economic impact of Washington's life sciences industry and to promote the growth and success of the sector.

We Work for Health will release the results of a groundbreaking study demonstrating the economic impact of the life sciences and biopharmaceutical sector in Washington state. The study will highlight the number of jobs created directly and indirectly by the biotechnology, biopharmaceutical, biomedical and research companies that make Washington an international hub for life sciences innovation.

WHAT

News conference to launch We Work for Health, a statewide economic development and jobs advocacy coalition.

Release of job creation and economic impact study by Archstone Consulting of biopharmaceutical and related industries in Washington state.

Tour of Seattle Children's Research Institute to illustrate importance of life sciences jobs in Washington state.

    WHEN
    Thursday, April 23, 2009
    10 a.m. News Conference
    10:45 a.m. Tour of Seattle Children's Research Institute with President James B. Hendricks, PhD.

    WHERE
    Seattle Children's Research Institute
    Soundgarden Room, 11th floor
    1900 9th Ave.
    Seattle, WA 98101

Complimentary parking is available in the Diamond Parking garage in the Children's building. The entrance is located in the alley off Stewart Street between 9th and Terry.

WHO

We Work for Health Co-Chairs

  • Bob Drewel, Executive Director, Puget Sound Regional Council
  • Dr. Elson S. Floyd, President, Washington State University
  • Dr. Lee Huntsman, Executive Director, Life Sciences Discovery Fund
  • Chris Rivera, President, Washington Biotechnology and Biomedical Association
  • Rogers Weed, Director of the Washington State Department of Community, Trade and Economic Development

Presenter

Michael Eckstut, Life Sciences Practice Leader, Archstone Consulting

BACKGROUND

We Work for Health is a statewide effort uniting organizations, companies, individuals and other stakeholders around a common goal: to educate policymakers and key opinion leaders about the economic impact of the life sciences innovation pipeline and to promote and grow the industry in Washington state. We Work for Health seeks to raise awareness of the impact of public policy on innovation in the life sciences, related industries and surrounding communities.

Media Contacts: Chelsea Waliser or Nate Cole-Daum, Nyhus Communications LLC for We Work for Health, (206) 323-3733 | chelsea@nyhus.com or nate@nyhus.com


'/>"/>
SOURCE We Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caliper Life Sciences First Quarter 2009 Financial Results Conference Call Notice
2. Gene Network Sciences Announces Brain Cancer Collaboration With M.D. Anderson
3. HBO, UCSD Shiley-Marcos Alzheimers Disease Research Center, The Alzheimers Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMERS PROJECT: MOMENTUM IN SCIENCE
4. Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
5. Advanced Life Sciences Announces Results of Shareholder Meeting and Provides Additional Information on Upcoming Advisory Committee Meeting
6. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
7. Derma Sciences Reports Fourth Quarter, Year-End Results for 2008
8. Human Pheromone Sciences Announces Fourth Quarter and Full Year Results
9. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
10. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
11. Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology: